Vir Biotechnology Inc.
Clinical‑stage biotech focused on novel therapeutics for serious infectious diseases and oncology, with a pipeline including hepatitis D, solid tumors, and antiviral candidates, supported by partnerships with Gates Foundation, Alnylam, Sanofi and GSK.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 408
- HQ: San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.